Diagnostic, Treatment, and System Challenges in the Management of Recurrent Neuroleptic Malignant Syndrome on a General Medical Service
Neuroleptic malignant syndrome (NMS), an iatrogenic form of malignant catatonia, carries high morbidity and mortality rates especially in the context of delayed recognition and standard intervention protocol of lorazepam trial. However, there is limited guidance available through literature for furt...
Saved in:
Main Authors: | Karan Verma, Vivek Jayadeva, Raymond Serrano, Karthik Sivashanker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2018/4016087 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroleptic Malignant Syndrome: Diagnostic and Therapeutic Dilemmas
by: Abebaw Fekadu, et al.
Published: (2005-01-01) -
Neuroleptic Malignant Syndrome Caused by a Combination of Carbamazepine and Amitriptyline
by: A. Bruce Janati, et al.
Published: (2012-01-01) -
Neuroleptic Malignant Syndrome: A Case Aimed at Raising Clinical Awareness
by: Jad Al Danaf, et al.
Published: (2015-01-01) -
Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone
by: Paras Agarwal, et al.
Published: (2021-01-01) -
Paliperidone Inducing Concomitantly Syndrome of Inappropriate Antidiuretic Hormone, Neuroleptic Malignant Syndrome, and Rhabdomyolysis
by: Jaspinder Kaur, et al.
Published: (2016-01-01)